MedPath
NMPA Approval

Macrogol Sodium Potassium Powder

国药准字H20253275

January 24, 2025

Drug Information

聚乙二醇钠钾散

散剂

本品为复方制剂,每包含聚乙二醇3350为13.1250g、氯化钠0.3507g、氯化钾0.0466g、碳酸氢钠0.1785g

化学药品

January 24, 2025

Company Information

Applicant Company

浙江省丽水市龙泉市炉田工业园区科伦大道9号

Manufacturing Company

浙江省龙泉市炉田工业园区科伦大道9号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

聚乙二醇钠钾散 - NMPA 批准文号 | MedPath